Unless explicitly stated, any brand names included in brackets next to a drug's generic name are there solely to aid searching and identification, and should not be considered to limit use to that specific brand.
Treatment of glaucoma
Drugs that reduce intra-ocular pressure are used for managing glaucoma; they act by a variety of mechanisms. A topical beta-blocker or a prostaglandin analogue is commonly the drug of first choice. It may be necessary to combine these drugs or add others such as miotics, sympathomimetics and carbonic anhydrase inhibitors to control intra-ocular pressure.
Latanoprost, tafluprost and travoprost are prostaglandin analogues which increase uveoscleral outflow; bimatoprost is a related drug. They are used to reduce intra-ocular pressure in ocular hypertension or in open-angle glaucoma. Patients receiving prostaglandin analogues should be monitored for any changes to eye coloration since an increase in the brown pigment in the iris may occur; particular care is required in those with mixed coloured irides and those receiving treatment to one eye only.
Green - Drugs suitable for generalised use in accordance with position summary.
Inform primary care of need to prescribe using a TTO chart if in patient or Treatment Advice Note (TAN) if Outpatient.
Amber - these drugs require specialist initiation or recommendation
Amber Share Care - Drugs suitable for generalist use, in accordance with position summary, normally following specialist initiation and stabilisation. Ongoing division of responsibility for drug and disease monitoring between specialist and GP by a Shared Care Guideline (SCG). If no SCG in place status reverts to red.
Red - Drugs for specialist use only, in accordance with position summary. GP’s should not be asked to prescribe these products.
Red ULM - Unlicensed medicines for specialist use only, in accordance with position summary. GP’s should not be asked to prescribe these products.
Grey drugs - No formal commissioning position. Check appropriate CCG /NHSE commissioning list or contact CCG/NHSE Medicines Management team for advice. Fill in individual funding request for appropriate CCG/NHSE. This will need to be signed by the Chief Pharmacist and a copy of the relevant DTC submission attached.
Black - Drugs not routinely commissioned so should not usually be prescribed